Vivos Inc (RDGL)

$0.09 +0.00 (0.90%)
Market Cap 40.86M
Revenue (ttm) 30,000.00
Net Income (ttm) -2.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,700.00%
Debt to Equity Ratio 0.00
Volume 935,700
Avg Vol 1,800,416
Day's Range N/A - N/A
Shares Out 454.55M
Stochastic %K 60%
Beta 1.04
Analysts Strong Buy
Price Target N/A

Company Profile

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing a universal laboratory cooling device; hydro...

Industry: Medical Devices
Sector: Healthcare
Phone: 509 222 2222
Address:
1030 N Center Parkway, Suite N288, Kennewick, United States
mc73307
mc73307 Oct. 3 at 9:51 PM
$RDGL In my perfect dream world this proce continues to drop to 1 cent. Then i can buy 1M shares...then they get IDE approval and price jumps up to a dollar. I win, cancer patients win. Too bad the FDA is blatently inept and corrupt.
1 · Reply
anderson800
anderson800 Oct. 3 at 6:39 PM
$RDGL someone has a big 500k shares order sitting on the buy side right now. Wondering if they are going to move up their bid as we get closer to the close.
2 · Reply
Doccjc62
Doccjc62 Oct. 3 at 2:06 PM
$RDGL Patience here is tough, but catalysts like the IDE and India decision are what can flip this from range-bound to breakout
1 · Reply
Den44
Den44 Oct. 2 at 4:34 PM
$RDGL We are honored to be attending the European Association of Nuclear Medicine for the first time. Our focus is advancing awareness of Precision Radionuclide Therapy™, our innovative cancer treatment designed to bring new hope to patients worldwide.
0 · Reply
Daybyday5
Daybyday5 Oct. 1 at 1:55 PM
$RDGL 30 mins. Volume 0. Great!
0 · Reply
Aerovestorman
Aerovestorman Oct. 1 at 12:10 PM
$RDGL Korenko is brilliant. The India strategy just might encourage the FDA to look at $RDGL seriously. Big Pharma will eventually look closer at Vivos, Inc. because they will not want to let this slip through their greedy fingers. Just a thought😉
0 · Reply
Daybyday5
Daybyday5 Sep. 30 at 2:22 PM
$RDGL so sad, there are still safety concerns..... Based on feedback from the FDA, as part of our IDE application process, our formal protocol for the next phase of human trials in India will include immediate post treatment PET full- body scans to further validate RadioGel’s safety profile.
1 · Reply
PhillyZ23
PhillyZ23 Sep. 29 at 12:43 PM
$RDGL https://www.globenewswire.com/news-release/2025/09/29/3157721/0/en/Vivos-Inc-Board-Authorizes-Vivios-Inc-to-Establish-a-Corporate-Entity-in-India.html
2 · Reply
Doccjc62
Doccjc62 Sep. 24 at 8:52 PM
$RDGL Pretty quiet here lately ,unless Daybyday,aka Sasha is posting some crazy stuff . Fortunatley ,I can't read her posts . Looks like we're waiting for an IDE update, or the upcoming DCGI decision. Hopefully we get an updatre soon.
1 · Reply
Daybyday5
Daybyday5 Sep. 24 at 4:31 PM
$RDGL Brad Weeks has been with vivos for almost 2 years as a business development manager and now he's the president. I wonder if it's good news or not. Does the new title change much? He claims to be responsible for several FDA clearances yet the company failed twice while he was parts of the team... I seriously hope him and the mysterious FDA consultant is not the same person.
1 · Reply
Latest News on RDGL
No data available.
mc73307
mc73307 Oct. 3 at 9:51 PM
$RDGL In my perfect dream world this proce continues to drop to 1 cent. Then i can buy 1M shares...then they get IDE approval and price jumps up to a dollar. I win, cancer patients win. Too bad the FDA is blatently inept and corrupt.
1 · Reply
anderson800
anderson800 Oct. 3 at 6:39 PM
$RDGL someone has a big 500k shares order sitting on the buy side right now. Wondering if they are going to move up their bid as we get closer to the close.
2 · Reply
Doccjc62
Doccjc62 Oct. 3 at 2:06 PM
$RDGL Patience here is tough, but catalysts like the IDE and India decision are what can flip this from range-bound to breakout
1 · Reply
Den44
Den44 Oct. 2 at 4:34 PM
$RDGL We are honored to be attending the European Association of Nuclear Medicine for the first time. Our focus is advancing awareness of Precision Radionuclide Therapy™, our innovative cancer treatment designed to bring new hope to patients worldwide.
0 · Reply
Daybyday5
Daybyday5 Oct. 1 at 1:55 PM
$RDGL 30 mins. Volume 0. Great!
0 · Reply
Aerovestorman
Aerovestorman Oct. 1 at 12:10 PM
$RDGL Korenko is brilliant. The India strategy just might encourage the FDA to look at $RDGL seriously. Big Pharma will eventually look closer at Vivos, Inc. because they will not want to let this slip through their greedy fingers. Just a thought😉
0 · Reply
Daybyday5
Daybyday5 Sep. 30 at 2:22 PM
$RDGL so sad, there are still safety concerns..... Based on feedback from the FDA, as part of our IDE application process, our formal protocol for the next phase of human trials in India will include immediate post treatment PET full- body scans to further validate RadioGel’s safety profile.
1 · Reply
PhillyZ23
PhillyZ23 Sep. 29 at 12:43 PM
$RDGL https://www.globenewswire.com/news-release/2025/09/29/3157721/0/en/Vivos-Inc-Board-Authorizes-Vivios-Inc-to-Establish-a-Corporate-Entity-in-India.html
2 · Reply
Doccjc62
Doccjc62 Sep. 24 at 8:52 PM
$RDGL Pretty quiet here lately ,unless Daybyday,aka Sasha is posting some crazy stuff . Fortunatley ,I can't read her posts . Looks like we're waiting for an IDE update, or the upcoming DCGI decision. Hopefully we get an updatre soon.
1 · Reply
Daybyday5
Daybyday5 Sep. 24 at 4:31 PM
$RDGL Brad Weeks has been with vivos for almost 2 years as a business development manager and now he's the president. I wonder if it's good news or not. Does the new title change much? He claims to be responsible for several FDA clearances yet the company failed twice while he was parts of the team... I seriously hope him and the mysterious FDA consultant is not the same person.
1 · Reply
dk67
dk67 Sep. 24 at 3:46 PM
$RDGL New President: Check out Brad Weeks’ profile on LinkedIn https://www.linkedin.com/in/brad-weeks-76333079?utm_source=share&utm_medium=member_mweb&utm_campaign=share_via&utm_content=profile
0 · Reply
Daybyday5
Daybyday5 Sep. 23 at 3:06 PM
$RDGL Brad Weeks linkdin profile deleted....
1 · Reply
anderson800
anderson800 Sep. 22 at 1:57 PM
$RDGL President Weeks
2 · Reply
anderson800
anderson800 Sep. 22 at 1:56 PM
$RDGL https://www.sec.gov/Archives/edgar/data/1449349/000149315225014345/ex10-2.htm
1 · Reply
anderson800
anderson800 Sep. 22 at 1:55 PM
$RDGL https://www.sec.gov/Archives/edgar/data/1449349/000149315225014345/ex10-1.htm
0 · Reply
Rogggggg
Rogggggg Sep. 22 at 1:38 PM
$RDGL
0 · Reply
Balnsac
Balnsac Sep. 19 at 2:53 PM
$RDGL one of these days 🚀
2 · Reply
Elonlies
Elonlies Sep. 19 at 11:13 AM
$RDGL Can someone post the link regarding Vivos India?
3 · Reply
Daybyday5
Daybyday5 Sep. 18 at 3:13 PM
$RDGL
2 · Reply
Doccjc62
Doccjc62 Sep. 17 at 3:39 PM
$RDGL I think RDGL’s next update could be the IDE decision itself, not just the resubmission — similar to how they handled the BDD announcement. Could come sooner than many expect.
2 · Reply
Doccjc62
Doccjc62 Sep. 15 at 3:16 PM
$RDGL https://x.com/isopetforcancer/status/1967605172668178494?s=46&t=vL-KXYXZYnhJDJaIoa-ARw
1 · Reply
Fireballmillionaire
Fireballmillionaire Sep. 14 at 7:03 PM
$RDGL does anyone know human trials process in India?? Is there a timeline??
2 · Reply